Medication info
Huni's Risedronate Sodium Tablet (Risedronate Sodium Hemihydrate 2.5)

Huni's Risedronate Sodium Tablet (Risedronate Sodium Hemihydrate 2.5)

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.2mg / 1 tablet
Manufacturer / importer
Huons Meditec Co., Ltd.
Appearance
Yellow rectangular film-coated tablets
Packaging
4 tablets (PTP packaging)
Approval status
Active

MFDS item code 201503783 · Approved 2015.06.10 · Insurance code 670400980

Summary

Main use
Treatment and prevention of osteoporosis in postmenopausal women, and treatment of osteoporosis in men
Who takes it
Adults · Children
Adult dose
1. Adults: Administer 35 mg of risedronate sodium orally once weekly. 2. Elderly patients: No dose adjustment is necessary in elderly patients (over 60 years of age), since the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary in patients with creatinine clearance of 30 mL/min or more. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before breakfast or at least 2 hours before or after food or beverages at any time of day. To help the medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with plenty of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled day, they should take it the next morning when they remember. Resume the usual schedule for the next dose. Do not take 2 tablets on the same day.
Child dose
3. Children: The safety and efficacy in children under 18 years of age have not been established.

Ingredients

Manufacturer
Huons Meditec Co., Ltd.

Efficacy & effects

Treatment and prevention of osteoporosis in postmenopausal women, and treatment of osteoporosis in men

  • Osteoporosis
View approved original text

This medication is used for the treatment and prevention of osteoporosis in postmenopausal women and men. Osteoporosis is a condition where bones become weak and can fracture easily, and this medication helps to increase bone density and reduce fracture risk. Therefore, it is used to prevent fractures due to osteoporosis and improve bone health.

How to take

Adult dose

1. Adults: Administer 35 mg of risedronate sodium orally once weekly. 2. Elderly patients: No dose adjustment is necessary in elderly patients (over 60 years of age), since the bioavailability and pharmacodynamics of this medicine are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary in patients with creatinine clearance of 30 mL/min or more. This medicine is contraindicated in patients with severe renal impairment and creatinine clearance below 30 mL/min. ○ Food interferes with the absorption of this medicine. For adequate absorption, take it at least 30 minutes before breakfast or at least 2 hours before or after food or beverages at any time of day. To help the medicine reach the stomach easily and reduce the possibility of esophageal irritation, take it in an upright position with plenty of plain water (170 ∼ 230 mL). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this medicine on the scheduled day, they should take it the next morning when they remember. Resume the usual schedule for the next dose. Do not take 2 tablets on the same day.

Child dose

3. Children: The safety and efficacy in children under 18 years of age have not been established.

Precautions

This medication is an oral bisphosphonate, and it is used to strengthen bones. However, it can irritate the stomach and esophagus, so patients with esophageal diseases, gastritis, or ulcers should take it with caution. When taking, sit or stand while taking with a sufficient amount of water, and do not lie down for at least 30 minutes after taking. If difficulty swallowing or symptoms such as chest pain or heartburn occurs, discontinue use immediately and consult a physician. This medication should not be administered to patients with esophageal strictures, hypocalcemia, severe renal impairment, or to women who are pregnant or breastfeeding. Patients with specific genetic problems such as lactose intolerance should also avoid taking it. While taking this medication, it is important to consume enough calcium and vitamin D, and caution is needed as the presence of medications containing divalent cations such as calcium or iron may interfere with the absorption of this medication. Rarely, prolonged use of this medication can lead to serious side effects such as osteonecrosis of the jaw or atypical femoral fractures, so consult a physician immediately if any abnormal symptoms occur. Additionally, this medication may have gastrointestinal symptoms (abdominal pain, diarrhea, nausea, etc.), musculoskeletal pain, headache, rash, and if symptoms persist or are severe, inform healthcare professionals. Women who are pregnant should not take this medication as it may affect the fetus, and breastfeeding women should also discontinue use or stop breastfeeding. Safety in children under 18 years has not been established, and special caution is required for the elderly. In cases of overdose, hypocalcemia may occur, so visit a medical institution immediately for appropriate treatment. This medication should be stored out of reach of children and should not be transferred to another container.

Side effects

  • esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • gastric ulcer
  • duodenal ulcer
  • dyspepsia
  • diarrhea
  • abdominal pain
Show 40 more
  • nausea
  • arthralgia
  • arthritis
  • myalgia
  • bone pain
  • dizziness
  • depression
  • insomnia
  • bronchitis
  • sinusitis
  • rhinitis
  • pharyngitis
  • increased cough
  • rash
  • cataract
  • urinary tract infection
  • mucous membrane syndrome
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blisters
  • jawbone necrosis
  • iritis
  • uveitis
  • liver dysfunction
  • jaundice
  • loss of appetite
  • asthenia
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • eye pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering and kept at room temperature between 1 degree and 30 degrees to maintain its effectiveness and safety.

Appearance and packaging

Appearance

Yellow rectangular film-coated tablets

Package unit

4 tablets (PTP packaging)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.